Brief: Oncopeptides Q1 Operating Profit SEK -37.531 Million
13/05/2026 07:00
May 13 (Reuters) - Oncopeptides Q1 net income SEK -32.185 million. Q1 sales SEK 25.384 million Q1 adjusted EPS SEK -0.12 Q1 adjusted free cash flow SEK -45.592 million
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy